Sleep disorder business RMD is slowly recovering from its 16% correction from a late September high, yesterday’s rally took it back within striking distance of its October high and we remain positive targeting fresh all-time highs into 2022. We own RMD in our Flagship Growth Portfolio.
MM is bullish RMD looking for over 10% upside at least
Add To Hit List
